The Clinical Kinase Index: A Method to Prioritize Understudied Kinases as Drug Targets for the Treatment of Cancer-Reference-Cited by-同舟云学术

The Clinical Kinase Index: A Method to Prioritize Understudied Kinases as Drug Targets for the Treatment of Cancer

Published:2020-10 Issue:7 Volume:1 Page:100128
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Essegian Derek,Khurana Rimpi,Stathias Vasileios,Schürer Stephan C.

Funder

NIH

State of Florida Biomedical Research Program

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference85 articles.

1. DrugCentral: online drug compendium;Ursu;Nucleic Acids Res.,2017

2. Novel drug targets in 2018;Ursu;Nat. Rev. Drug Discov.,2019

3. DrugCentral 2018: an update;Ursu;Nucleic Acids Res.,2019

4. Tyrosine-kinase inhibitors in the treatment of muscle invasive bladder cancer and hormone refractory prostate cancer;Wallerand;Arch. Esp. Urol.,2010

5. Emerging kinase inhibitors of the treatment of gastric cancer;Vincenzi;Expert Opin. Emerg. Drugs,2015

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening of a kinase inhibitor library identified novel targetable kinase pathways in triple-negative breast cancer;Anti-Cancer Drugs;2024-08-21

2. Safety Implications of Modulating Nuclear Receptors: A Comprehensive Analysis from Non-Clinical and Clinical Perspectives;Pharmaceuticals;2024-07-03

3. Navigating the Maze of Kinases: CaMK-like Family Protein Kinases and Their Role in Atherosclerosis;International Journal of Molecular Sciences;2024-06-05

4. Overexpression of TSPAN8 in consensus molecular subtype 3 colorectal cancer;Experimental and Molecular Pathology;2024-06

5. Meta-Research: Understudied genes are lost in a leaky pipeline between genome-wide assays and reporting of results;eLife;2024-03-28